Funded Tech Companies
Cardioxyl Pharmaceuticals
Cardioxyl Pharmaceuticals was a leading biopharmaceutical company, based in Chapel Hill. The company was acquired by Bristol-Meyers Squibb.
Company Overview
Company Name
Cardioxyl Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1450 Raleigh Rd. 212
Chapel Hill, NC 27517
USA
Chapel Hill, NC 27517
USA
Phone
Website
Email Address
Company Background Information
Overview
Cardioxyl Pharmaceuticals' mission is the discovery and development of newclasses of safe and effective therapeutic agents for the treatment ofcardiovascular disease. Cardioxyl's initial program is a novel medication forthe treatment of acute decompensated heart failure.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/2/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Kroeger
Chief Medical Officer
Shi Foo
Chief Scientific Officer
John Reardon
VP - Regulatory Affairs
Doug Cowart
Company Investors
- OrbiMed (Anthony Johnson)
- New Enterprise Associates (James Barrett)
- Osage Partners (William Harrington)
- Aurora Funds (Jeffrey Clark)
- Aurora Funds (Christopher Kroeger)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs